Impacting lives of patients today and raising awareness of innovative healthcare solutions.​

About Diagnostics4life

Future innovations. Impacting lives of patients today.

The founders of the DxPx Conference have always been motivated and inspired to improve the healthcare system. They have founded and built several companies focusing on diagnostics and life science tools. By establishing DxPx, they aim to bring people together to explore financing, licensing, and M&A opportunities and meet global leaders, investors & innovative growth companies from 30+ countries.

To further help communities that are not yet reached by current innovation and discoveries, the DxPx team along with its partners decided to launch the DxPx charity foundation called Diagnostics4Life. At every DxPx Conference, the team works with a partner organization and donates 5% to 10% of the conference ticket sales to these charities. We are glad of this opportunity to make an impact on the beneficiaries of these donations. Holding a conference every year with the intention of gathering industry leaders and experts focusing on Diagnostics, Digital Health, Precision Medicine, and Life Science tools is a great way to advance innovation. But leveraging on this conference to further inspire and contribute to the people who are not yet reached by the currently available innovations is an extra mile we want to do.

BGL’s Diagnostics, Research Tools & Medical Devices Investment Banking Team

The diagnostics, research tools, and medical device markets are large, vibrant, high-technology sectors. BGL provides capital formation, technology strategy, corporate ventures, and medical device M&A strategy for — and is a trusted and prominent advisor to — a wide range of diagnostics, research tools, and device companies. We maintain active relationships with global industry participants and capital providers, and closely follow regulatory and reimbursement trends.

Keep informed with BGL’s research reports and insights articles analyzing healthcare industry issues and trends.

Learn more

McDermott Healthcare

Legal 500, UK 2021

Today’s global healthcare marketplace is marked by unprecedented transformation and opportunity. Healthcare delivery and reimbursement is shifting toward value-based care and vertical consolidation at a rapid pace, as systems, health plans and other forward-thinking leaders join forces to tackle some of the industry’s biggest challenges. Digital health solutions are evolving the doctor-patient relationship beyond the in-person encounter—fundamentally transforming the quality and delivery of healthcare. And investors are taking notice.

Learn more

lino Biotech

lino Biotech has been supporting DxPx since 2020 and offers the world´s only biosensors based on Focal Molography. This entirely new method for measuring molecular interactions in living cells or crude biological samples has the potential to offer a low-cost and very robust point-of-care diagnostic that can be used even in developing countries. Currently, the company offers solutions to help manufacturers of cell & gene therapies to address challenges in manufacturing and upscaling. Learn more about Focal Molography by watching the video.

Learn more
thanks to

our knowledge partners and sponsors

These are all possible with the continuous support of our knowledge partners and sponsors all through the years. In this portion, we want to take the chance to feature the innovative and promising projects our partners have been working on. We believe that these are essential and beneficial to improving the quality of human life. We are hopeful and certain that these discoveries will inspire and motivate startups and growth companies in the field of the Diagnostics, Digital Health, Precision Medicine, and Life Science tools to launch products and services that will create solutions to the daily healthcare needs of humanity.

Dedicated to achieving better health through laboratory medicine, AACC brings together more than 74,000 clinical laboratory professionals, physicians, research scientists, and business leaders from around the world focused on clinical chemistry, molecular diagnostics, mass spectrometry, translational medicine, lab management, and other areas of progressing laboratory science. Since 1948, AACC has worked to advance the common interests of the field, providing programs that advance scientific collaboration, knowledge, expertise, and innovation. For more information, visit www.aacc.org.​

Brown Gibbons Lang & Company (BGL) is a leading independent investment bank and financial advisory firm focused on the global middle market. The firm advises private and public corporations and private equity groups on mergers and acquisitions, capital markets, financial restructurings, valuations and opinions, and other strategic matters. BGL has investment banking offices in Chicago, Cleveland, Los Angeles, and New York, and real estate offices in Chicago, Cleveland, and San Antonio. The firm is also a founding member of Global M&A Partners, enabling BGL to service clients in more than 30 countries around the world. Securities transactions are conducted through Brown, Gibbons, Lang & Company Securities, LLC, an affiliate of Brown Gibbons Lang & Company LLC and a registered broker-dealer and member of FINRA and SIPC. For more information, please visit www.bglco.com.

lino Biotech is the world´s only provider of Focal Molography – an entirely new method for measuring molecular interactions in living cells or crude biological samples. The broadly patented technology offers label-free detection assays while eliminating signal disturbances due to temperature changes or non-specific binding. lino Biotech was incorporated in Zürich, Switzerland, in March 2020 with the aim to make cell therapies more cost effective and accessible for a broader patient population by offering new quality control method that every cell therapy manufacturer can use to improve their production and development process.

McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. With 20+ locations globally, our team works seamlessly across practices, industries, and geographies to deliver highly effective—and often unexpected—solutions that propel success.​

McDermott’s Life Sciences Team will get you closer to your goals. Composed of top lawyers with demonstrated strength across intellectual property, regulatory, transactional, and litigation law, we’re a purpose-built team of thought leaders united by a passion for our work. Their team can meet the legal needs of life sciences companies at every stage of development. For decades, they have embraced the value of focused knowledge, harnessing both the particular skills of individuals and the collective experience of their team. This makes them uniquely qualified to help you move business initiatives across the finish line when it matters and anticipate what’s next.​

McKinsey & Company is a global management consulting firm. They are the trusted advisor to the world’s leading businesses, governments, and institutions. They work with leading organizations across the private, public and social sectors. Our scale, scope, and knowledge allow us to address problems that no one else can. They have deep functional and industry expertise as well as breadth of geographical reach. They are passionate about taking on immense challenges that matter to our clients and, often, to the world. ​

The McKinsey Cancer Center helps life sciences organizations discover, develop, and distribute more effective medicines, deliver better care, and provide broader access to solutions that help patients and their families combat cancer.​

SLS Partnering is an event and marketing agency that tailors its services to the specific needs of the Life Science industry. Built by scientists and marketeers, SLS Partnering is your trusted partner to translate technology and scientific content into high-quality marketable stories that trigger interest and emotion with customers and investors. SLS Partnering is the official organizer of the DxPx Conference focusing on Diagnostics, Digital Health, Precision Medicine and Life Science Tools.​

About DxPx:​

DxPx was first hosted in 2019 as an international Industry & Investor Partnering Conference for executives from the Diagnostics, Digital Health, Precision Medicine & Life Science Tools industry to explore financing, licensing, and M&A opportunities. The annual flagship conference takes place each November in Dusseldorf, Germany, and is accompanied by conferences in the US and China throughout the year.